← All Allarity Therapeutics, INC filings

Allarity Therapeutics, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NASDAQ
ALLR
Allarity Therapeutics, INC
S-1/A: Allarity Therapeutics Seeks $10 Million in Public Offering Amid Nasdaq Delisting Concerns
Allarity Therapeutics is offering 5,000,000 shares of common stock at an assumed price of $2.00 per share to raise capital while facing potential delisting from the Nasdaq Capital Market.
NASDAQ
ALLR
Allarity Therapeutics, INC
S-1/A: Allarity Therapeutics Seeks $8 Million in Best Efforts Offering to Fund Stenoparib Trial and Repurchase Preferred Stock
Allarity Therapeutics aims to raise up to $8 million through a best efforts offering of common stock, warrants, and pre-funded warrants to advance its stenoparib clinical trial and potentially repurchase Series A Preferred Stock.